Life Sciences andHealthcare
Our team guides life sciences and healthcare companies
through the complex compliance obligations,transactions and litigation that enable them to advancethe breakthrough treatments and services that improve
patient health. We combine extensive life sciencesindustry capabilities and our long history as a leading
healthcare industry adviser to counsel clients across thedelivery system on FDA law, health law, productliability, M&A, appellate litigation, data privacy andsecurity, government advocacy and more.
An established leader in life sciences and healthcare. We
have a long history as the firm of choice for pharmaceutical,biologics and medical device manufacturers and major
hospitals and health systems. The Chambers and Legal 500
guides consistently rank our practice and its lawyers among
the best in the life sciences and healthcare field.
At the forefront of industry innovation. We assist
development-stage clients operating in emerging areas
where technology intersects with medical care, including
precision medicine, artificial intelligence, and innovations indigital health.
Bringing the right resources to the table. We anticipate
shifting market trends and grow and evolve our team to help
our clients respond to them. Most recently, we have
expanded our capabilities in food and beverage litigation,
biologics counseling, global human global human capitaland compliance, and government contracts, among otherareas.

CapabilityLawyers
Mark D. Polston
Washington, D.C.

Nikki Reeves
Washington, D.C.

James W. Boswell III (Jim)
AtlantaMark S. Brown
Washington, D.C.

Richard Zall (Rick)
New York

Adam C. Solander
Washington, D.C.

Recognition
Recognized nationwide as‘Healthcare: The Elite’
CHAMBERS USA 2022

Cases & Deals
August 27, 2024
King & Spalding Secures Summary Judgment Wins for
Merck and Organon in Nationwide Litigation
July 8, 2024
King & Spalding advises TVM Capital Healthcare on its$35 million investment into Boston Oncology Arabia
June 21, 2024

LMG Life Sciences named
20 K&S lawyers as ‘Life
Sciences Stars’ in the 2021
editionLMG LIFE SCIENCES

Ranked as one of theSharecare Enters into Definitive Agreement to be Acquiredby Altaris
VIEW ALL

leading firms in
Pharmaceutical and Medical
Products Regulatory
CHAMBERS USAInsights
CLIENT ALERT
August 23, 2024
Predetermined Change Control Plans (PCCPs) for
Medical Devices: FDA Issues Draft Guidance
CLIENT ALERTJuly 22, 2024
EU Artificial Intelligence Regulation Published - What You
Need to Know
CLIENT ALERTJuly 12, 2024
FDA Issues Updated Draft Guidance on Addressing
Misinformation About Medical Devices and Prescription
Drugs
VIEW ALL

Events
CONFERENCE
September 30, 2024
Annual Health Law & Policy Forum West
SPEAKING ENGAGEMENT
September 20, 2024
Tom Hawk to Speak at Samford University Cumberland
School of Law’s annual healthcare CLE
SPEAKING ENGAGEMENT
September 18, 2024
Peter Hsiao to Speak at Think Forward the Future of Food
Conference
VIEW ALLNews
RECOGNITION
September 19, 2024
King & Spalding Earns Multiple Rankings in LMG Life
Sciences 2024 Guide
PRESS RELEASE
September 16, 2024
Former DOJ Special Counsel and U.S. Attorney Robert
Hur and Associate White House Counsel Leah Grossi
Return to King & Spalding
IN THE NEWS
September 16, 2024
Former DOJ Special Counsel and U.S. Attorney Robert

Named Medical Device "Firmof the Year"LMG LIFE SCIENCES

Selected as a leading firm in
the nation in the Life
Sciences industry
LEGAL 500

Hur and Associate White House Counsel Leah Grossi
return as partners in the firm’s Special Matters andGovernment Investigations practice group in Washington,
D.C.
VIEW ALL